Bcl-2 antagonist killer 1 (BAK1) polymorphisms influence the risk of developing autoimmune rheumatic diseases in women

A. M. Delgado-Vega, J. Castiblanco, L. M. Gómez, L. M. Diaz-Gallo, A. Rojas-Villarraga, J. M. Anaya

Research output: Contribution to journalResearch Articlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Bcl-2 antagonist killer 1 (BAK1) polymorphisms influence the risk of developing autoimmune rheumatic diseases in women'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds